Safety and Efficacy Study of Gantenerumab in Participants With Early Alzheimer's Disease (AD)

Neurodegenerative Disorder
Alzheimer's Disease (AD)

Results
Download
Print

Study results

LPS WN39658 GRADUATE II Final Results November 2023 English (PDF, 0.8 MB)

LPS WN39658 GRADUATE II Final Results November 2023 Spain Spanish (PDF, 0.7 MB)

LPS WN39658 GRADUATE II Final Results November 2023 Japanese (PDF, 0.5 MB)

LPS WN39658 GRADUATE II Final Results November 2023 Portuguese (PDF, 1.0 MB)

What is Clinical Research?

In clinical research, volunteers, researchers, and medical professionals work together toward a shared goal: better treatment outcomes for patients. Clinical trials are vital to their process. They are carefully designed and follow approved protocols.

Safety and Efficacy Study of Gantenerumab in Participants With Early Alzheimer's Disease (AD)

Study results

LPS WN39658 GRADUATE II Final Results November 2023 English (PDF, 0.8 MB)

LPS WN39658 GRADUATE II Final Results November 2023 Spain Spanish (PDF, 0.7 MB)

LPS WN39658 GRADUATE II Final Results November 2023 Japanese (PDF, 0.5 MB)

LPS WN39658 GRADUATE II Final Results November 2023 Portuguese (PDF, 1.0 MB)

What is Clinical Research?

For the latest version of this information please go to www.forpatients.roche.com

Directly contact Roche for questions

Contact the hospital directly

Thank you

Something went wrong

Request a call back

Find participating medical centers and current study status in each of them

Safety and Efficacy Study of Gantenerumab in Participants With Early Alzheimer's Disease (AD)

For the latest version of this information please go to www.forpatients.roche.com